Remimazolam as a Novel Anesthetic in Pediatric Procedural Sedation and Anesthesia: A Narrative Review
Authors:
Open Access
- 19 June 2025
- journal article
- review article
- Published by Springer Nature in Cureus
- Vol. 17 (6) , e86354
Abstract
As an ultra-short-acting benzodiazepine, remimazolam demonstrates rapid onset, quick offset, and a short half-life. Current evidence suggests that its metabolism is not dependent on hepatic or renal function, and its effects can be reversed by flumazenil, a benzodiazepine antagonist. Ever since its approval for procedural sedation and general anesthesia, it has gained popularity due to its minimal impact on circulation and respiration and reduced incidence of adverse reactions. While the clinical application of remimazolam in adult and elderly patients has been studied and reported extensively, its safety and efficacy in pediatric patients remain unclear. Current evidence suggests its potential clinical value and application prospects in children. This review outlines the pharmacokinetics and pharmacodynamics of remimazolam and summarizes the latest research progress regarding its use in pediatric patients for procedural sedation and anesthetic induction and maintenance. We conducted a literature search using PubMed and the China National Knowledge Infrastructure (CNKI), specifically targeting clinical studies and case reports that evaluated the use of remimazolam for procedural sedation and general anesthesia in pediatric patients. The search strategy incorporated the following keyword combinations: "remimazolam and pediatric anesthesia", "remimazolam and pediatric sedation", "remimazolam and children", and "remimazolam and pediatric patients". In summary, we synthesized existing clinical studies and case reports to provide guidance and insights into the use and research of remimazolam in pediatric patients.Keywords
This publication has 93 references indexed in Scilit:
- Caution!! Reappearance of remimazolam effect after a flumazenil bolus: a larger bolus of flumazenil and a lower total remimazolam clearance are higher risksJournal of Anesthesia, 2022
- Chloral hydrate as a sedating agent for neurodiagnostic procedures in childrenCochrane Database of Systematic Reviews, 2021
- Re-sleeping after reversal of remimazolam by flumazenilJournal of Anesthesia, 2021
- Pharmacokinetics and pharmacodynamics of intranasal remimazolam—a randomized controlled clinical trialEuropean Journal of Clinical Pharmacology, 2020
- Time‐to‐Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General AnesthesiaThe Journal of Clinical Pharmacology, 2020
- Preoperative Evaluation of the Pediatric PatientAnesthesiology Clinics, 2018
- Propofol: A Review of its Role in Pediatric Anesthesia and SedationCNS Drugs, 2015
- Effects of sevoflurane versus other general anaesthesia on emergence agitation in childrenCochrane Database of Systematic Reviews, 2014
- Chloral hydrate in pediatric magnetic resonance imaging: evaluation of a 10-year sedation experience administered by radiologistsPediatric Radiology, 2014
- The child with glutaric aciduria type I: anesthetic and perioperative managementJournal of Anesthesia, 2011